Viewing Study NCT07372118


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-04-01 @ 11:04 AM
Study NCT ID: NCT07372118
Status: COMPLETED
Last Update Posted: 2026-01-28
First Post: 2026-01-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg in Fast Condition
Sponsor: Humanis Saglık Anonim Sirketi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module